Molecular Features and Pathways in Predicting Drug Resistance in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide

Clinical trial NCT02228265 · COMPLETED

Trial details

NCT number: NCT02228265
Sponsor: OHSU Knight Cancer Institute
Status: COMPLETED
Study type: OBSERVATIONAL

Castration Levels of Testosterone Castration-Resistant Prostate Carcinoma Prostate Adenocarcinoma PSA Progression Recurrent Prostate Carcinoma Stage IV Prostate Cancer

Start date: 2013-03-12
Primary completion: 2019-10-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.